Kimberly Blackwell

Insider Reports History

Entity
Individual
Location
C/O Zentalis Pharmaceuticals, Llc, 530 Seventh Avenue, Suite 2201, New York, NY
Signature
/s/ Douglas Carr, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kimberly Blackwell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 484K $5.66M $11.69 Feb 1, 2024 Direct
Zentalis Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 250K Feb 1, 2024 Direct
Century Therapeutics, Inc. Director Stock Option (right to buy) 44K Jun 20, 2024 Direct
Monte Rosa Therapeutics, Inc. Director Stock Option (Right to Buy) 22.1K Jun 12, 2024 Direct

Insider Reports Filed by Kimberly Blackwell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IPSC Century Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 12, 2024 1 $0 4 Jun 13, 2024 Director
ZNTL Zentalis Pharmaceuticals, Inc. Feb 1, 2024 3 -$241K 4 Feb 5, 2024 Chief Executive Officer, Director
ZNTL Zentalis Pharmaceuticals, Inc. Nov 13, 2023 1 $51.4K 4 Nov 13, 2023 Chief Executive Officer, Director
IPSC Century Therapeutics, Inc. Jun 27, 2023 1 $0 4 Jun 29, 2023 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
ZNTL Zentalis Pharmaceuticals, Inc. Feb 1, 2023 2 $0 4 Feb 1, 2023 Chief Executive Officer, Director
GLUE Monte Rosa Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
IPSC Century Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
ZNTL Zentalis Pharmaceuticals, Inc. May 16, 2022 2 $0 4 May 20, 2022 President & CEO, Director
ZNTL Zentalis Pharmaceuticals, Inc. Jan 3, 2022 3 -$35.9K 4 Jan 5, 2022 Director
ZNTL Zentalis Pharmaceuticals, Inc. Dec 1, 2021 3 -$34K 4 Dec 2, 2021 Director
ZNTL Zentalis Pharmaceuticals, Inc. Nov 1, 2021 3 -$32.7K 4 Nov 2, 2021 Director
ZNTL Zentalis Pharmaceuticals, Inc. Oct 25, 2021 3 -$77.6K 4 Oct 27, 2021 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 Director
IPSC Century Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
IPSC Century Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 Director
ZNTL Zentalis Pharmaceuticals, Inc. Jun 4, 2021 2 $0 4 Jun 8, 2021 Director
GLUE Monte Rosa Therapeutics, Inc. Apr 12, 2021 2 $0 4 Jun 25, 2021 Director